filmov
tv
FSD PHARMA looking at acquisitions as it continues its build out of facility in Ontario
Показать описание
FSD Pharma Inc. (OTCQB:FSDDF)(CSE:HUGE) Interim CEO Raza Bokhari sat down with Christine Corrado from Proactive Investors New York at the 11th Annual Biotech Showcase in San Francisco. The Canadian cannabis company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Its cultivation facility is the former Kraft food production plant in Cobourg, Ontario, and is expected to be operational in the first quarter 2019.
0:04:20
FSD PHARMA looking at acquisitions as it continues its build out of facility in Ontario
0:04:08
FSD Pharma; Discussing the Acquisition of Lucid Psycheceuticals & More Updates
0:15:17
Growth STOCK | $HUGE Stock | FSD Pharma | Know Your CEO
0:00:46
FSD Pharma, Director Anthony Durkacz on CNBC
0:25:26
FSD Pharma Inc, Anthony Durkacz hosted a Mid-Summer Cannabis Investor Event
0:02:45
This is Going to Change Society: Kevin Harrington Speaks about FSD Pharma
0:01:00
FSD Pharma - Fabrice Taylor from Capital Ideas talks
0:04:56
FSD Pharma; Diving into Some Company Updates Including an Exciting Acquisition
0:16:58
FSD PHARMA Strengthens Drug Development With GW Pharma Executive Rupert Haynes
0:10:37
FSD Pharma; An Introduction to Anthony Durkacz & to the Company Itself
0:08:59
FSD Pharma is highlighted as today’s feature company by InvestmentPitch Media.
0:05:39
FSD Pharma; Recapping 2021 and What to Look Forward to in 2022
0:00:38
FSD PHARMA PHASE 1
0:00:17
FSD Pharma Inc.
0:00:08
Elon Musk Protected by his Humanoid Robot Bodyguard Eyes
0:09:12
FSD PHARMA Anthony Durkacz on Midas Letter Jan 30th 2019
0:04:23
FSD PHARMA appoints David Urban to Board of Directors - a high level government relations executive
0:00:47
FSD Pharma Inc (CNSX:HUGE) Pivoting to Medicinal Biotechnology
0:05:10
FSD PHARMA appoints Rupert Haynes as Chief Executive Officer
0:00:51
FSD Pharma Inc (CNSX:HUGE) Co-Founder on Role of Cannabis in Medical Paradigm Shift
0:03:31
FSD PHARMA partner Cannara Biotech has New Listing on CSE LOVE
0:03:41
Canntab Therapeutics and FSD Pharma Inc
0:08:15
FSD PHARMA'S partner Canntab Therapeutics calling their extended release tablet a game changer
0:18:47
FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)(CSE:HUGE)(FRA:0K9)
Комментарии